Replies to post #12650 on Generex Biotechnology Corp. (fka GNBTQ)

[Jimmy Joe]

WeeZuhl, question concerning COVID variants as this pandemic continues.
So listening to the GNBT CC from 10/08/2020, company seems very confident and positive about developing a vaccine now that they have secured funding.
Now looking at vaccine development to include children, infants, pregnant mothers. This vaccine would be a long term memory vaccine.

COVID constantly mutates.
Is one vaccine good for all mutations of COVID? Or will they have to fine tune the vaccine every so often to address these mutations?

Your thoughts please ....